LNS-AmB en es it fr

LNS-AmB Brand names, LNS-AmB Analogs

LNS-AmB Brand Names Mixture

  • No information avaliable

LNS-AmB Chemical_Formula


LNS-AmB RX_link


LNS-AmB fda sheet


LNS-AmB msds (material safety sheet)


LNS-AmB Synthesis Reference

No information avaliable

LNS-AmB Molecular Weight

924.079 g/mol

LNS-AmB Melting Point

170.0 oC

LNS-AmB H2O Solubility

750 mg/L

LNS-AmB State




LNS-AmB Dosage Forms

Slow intravenous-infusion

LNS-AmB Indication

Used to treat potentially life threatening fungal infections.

LNS-AmB Pharmacology

Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.

LNS-AmB Absorption

Bioavailability is 100% for intravenous infusion.

LNS-AmB side effects and Toxicity

Oral, rat: LD50 = >5 gm/kg. Amphotericin B overdoses can result in cardio-respiratory arrest.

LNS-AmB Patient Information

No information avaliable

LNS-AmB Organisms Affected

Various Fungus Species